Search

Thomas Brown

Examiner (ID: 11072)

Most Active Art Unit
2601
Art Unit(s)
2786, 2899, 2742, 2787, 2306, 2601, 2604, 2305, 2857
Total Applications
1242
Issued Applications
1062
Pending Applications
29
Abandoned Applications
151

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8779682 [patent_doc_number] => 20130101657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'ANGIOGENESIS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/627939 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24991 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13627939 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/627939
ANGIOGENESIS INHIBITORS Sep 25, 2012 Abandoned
Array ( [id] => 9607619 [patent_doc_number] => 08784782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions' [patent_app_type] => utility [patent_app_number] => 13/616585 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31385 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616585 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/616585
Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions Sep 13, 2012 Issued
Array ( [id] => 8904917 [patent_doc_number] => 20130172420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'LOW ENVIRONMENTAL IMPACT PESTICIDE MADE FROM \"GRAS\" INGREDIENTS FOR USE AGAINST COQUI FROGS AND OTHER SPECIES' [patent_app_type] => utility [patent_app_number] => 13/615117 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20016 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615117 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/615117
Low environmental impact pesticide made from “GRAS” ingredients for use against Coqui frogs and other species Sep 12, 2012 Issued
Array ( [id] => 10289069 [patent_doc_number] => 20150174068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'Apparatus, Composition, and Related Methods for Transdermal Delivery of Active Ingredients' [patent_app_type] => utility [patent_app_number] => 14/344455 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7546 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344455 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344455
Apparatus, Composition, and Related Methods for Transdermal Delivery of Active Ingredients Sep 11, 2012 Abandoned
Array ( [id] => 8697819 [patent_doc_number] => 20130059828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/601572 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12682 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601572 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/601572
PHARMACEUTICAL COMPOSITION Aug 30, 2012 Abandoned
Array ( [id] => 9581744 [patent_doc_number] => 08771745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 13/596904 [patent_app_country] => US [patent_app_date] => 2012-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11872 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13596904 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/596904
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof Aug 27, 2012 Issued
Array ( [id] => 10373133 [patent_doc_number] => 20150258139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'METHODS FOR TREATMENT OF CANCER USING LIPOPLATIN' [patent_app_type] => utility [patent_app_number] => 14/390352 [patent_app_country] => US [patent_app_date] => 2012-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15989 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390352 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/390352
METHODS FOR TREATMENT OF CANCER USING LIPOPLATIN Aug 12, 2012 Abandoned
Array ( [id] => 10528136 [patent_doc_number] => 09254250 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-02-09 [patent_title] => 'Molecules to perfect HbA1c levels' [patent_app_type] => utility [patent_app_number] => 13/570382 [patent_app_country] => US [patent_app_date] => 2012-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2983 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570382 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/570382
Molecules to perfect HbA1c levels Aug 8, 2012 Issued
Array ( [id] => 17140135 [patent_doc_number] => 20210308146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 13/566633 [patent_app_country] => US [patent_app_date] => 2012-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13566633 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/566633
PHARMACEUTICAL COMPOSITION Aug 2, 2012 Abandoned
Array ( [id] => 11879541 [patent_doc_number] => 09750696 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-05 [patent_title] => 'Dissolution enhanced controlled drug delivery system for poorly water soluble drugs' [patent_app_type] => utility [patent_app_number] => 14/236162 [patent_app_country] => US [patent_app_date] => 2012-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4707 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236162 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/236162
Dissolution enhanced controlled drug delivery system for poorly water soluble drugs Jul 31, 2012 Issued
Array ( [id] => 8611851 [patent_doc_number] => 20130017163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/548352 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 44409 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548352 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/548352
HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY Jul 12, 2012 Abandoned
Array ( [id] => 8609946 [patent_doc_number] => 20130015258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'Aromatic Adhesive-Backed Tab and Method of Using Same' [patent_app_type] => utility [patent_app_number] => 13/549082 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4455 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549082 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/549082
Aromatic adhesive-backed tab and method of using same Jul 12, 2012 Issued
Array ( [id] => 9222562 [patent_doc_number] => 20140017337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'THERAPEUTIC METHODS' [patent_app_type] => utility [patent_app_number] => 13/546202 [patent_app_country] => US [patent_app_date] => 2012-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30564 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13546202 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/546202
THERAPEUTIC METHODS Jul 10, 2012 Abandoned
Array ( [id] => 8482944 [patent_doc_number] => 20120282352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/544949 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10557 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13544949 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/544949
PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF Jul 8, 2012 Abandoned
Array ( [id] => 16138863 [patent_doc_number] => 10702485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Compositions and methods for overcoming resistance to tramadol [patent_app_type] => utility [patent_app_number] => 13/543883 [patent_app_country] => US [patent_app_date] => 2012-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 32 [patent_no_of_words] => 22349 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543883 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/543883
Compositions and methods for overcoming resistance to tramadol Jul 7, 2012 Issued
Array ( [id] => 8476762 [patent_doc_number] => 20120276170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'INJECTABLE DRUG CARRIER COMPRISING LAYERED DOUBLE HYDROXIDE' [patent_app_type] => utility [patent_app_number] => 13/541413 [patent_app_country] => US [patent_app_date] => 2012-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3831 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13541413 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/541413
Injectable drug carrier comprising layered double hydroxide Jul 2, 2012 Issued
Array ( [id] => 8478027 [patent_doc_number] => 20120277434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/539872 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16920 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539872 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/539872
METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS Jul 1, 2012 Abandoned
Array ( [id] => 8417615 [patent_doc_number] => 20120245115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => '1-Methylnicotinaide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities' [patent_app_type] => utility [patent_app_number] => 13/493703 [patent_app_country] => US [patent_app_date] => 2012-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13967 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13493703 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/493703
1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities Jun 10, 2012 Issued
Array ( [id] => 9656200 [patent_doc_number] => 20140227205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'TOPICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/124762 [patent_app_country] => US [patent_app_date] => 2012-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5707 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124762 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/124762
TOPICAL COMPOSITION Jun 5, 2012 Abandoned
Array ( [id] => 8417656 [patent_doc_number] => 20120245156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'ORAL LYOPHILIZED COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/487438 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12110 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487438 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/487438
ORAL LYOPHILIZED COMPOSITIONS Jun 3, 2012 Abandoned
Menu